Aplasia Cutis Congenita
- Author: Joy Wan, MD; Chief Editor: William D James, MD more...
Aplasia cutis congenita (ACC)[1, 2, 3] is a heterogenous group of disorders characterized by the absence of a portion of skin in a localized or widespread area at birth. First reported by Cordon in 1767, aplasia cutis congenita manifests as a solitary defect on the scalp in 70% of cases, but it may sometimes occur as multiple lesions. Although most commonly seen on the scalp, aplasia cutis congenita can affect any part of the body, including the trunk and limbs.
See 13 Common-to-Rare Infant Skin Conditions, a Critical Images slideshow, to help identify rashes, birthmarks, and other skin conditions encountered in infants.
The lesions of aplasia cutis congenita are noninflammatory and well-demarcated, ranging widely in size. They may be circular, oval, linear, or stellate in configuration. Aplasia cutis congenita occurring in a blaschkoid distribution has also been reported in 3 cases.[4, 5, 6] At birth, the lesions may have already healed with scarring or may remain superficially eroded to deeply ulcerated, occasionally involving the dura or the meninges. Defects in the skin that form early in gestation may heal before delivery and appear as an atrophic, membranous, bullous, or parchmentlike scar with associated alopecia, whereas less mature defects present as ulcerations. The membranous type of aplasia cutis congenita is most common.
Most lesions of aplasia cutis congenita occur on the scalp vertex just lateral to the midline, but defects may also occur on the face, trunk, or limbs, sometimes symmetrically. The defect may involve only the epidermis and upper dermis, resulting in minimal alopecic scarring, or it may extend into the deep dermis, subcutaneous tissue, or rarely periosteum, skull, and dura. Extension to deeper structures should be suspected in large, irregular lesions of aplasia cutis.
Aplasia cutis congenita is most often a benign isolated defect, but it can be associated with other physical anomalies or malformation syndromes.
Frieden created a classification system for aplasia cutis congenita consisting of 9 groups based on the number and location of the lesions and the presence or absence of associated malformations:
This is scalp aplasia cutis congenita without multiple anomalies. Nearly 86% of all solitary lesions occur on the scalp. A collar of hair is often seen around the defect, particularly with membranous aplasia cutis. It can be autosomal dominant or sporadic.
This is scalp aplasia cutis congenita with limb anomalies. Adams-Oliver syndrome[13, 14, 15, 16, 17] is a distinct disorder in which distal limb reduction abnormalities are found in association with solitary midline scalp defects. Adams-Oliver syndrome exhibits both autosomal dominant and autosomal recessive patterns of inheritance. In recent years, mutations in EOGT and DOCK6 have been identified as causes for autosomal recessive Adams-Oliver syndrome, and mutations in DLL4,ARHGAP31, RBPJ, and NOTCH1 have been observed in autosomal dominant forms of the syndrome.[18, 19, 20, 21, 22, 23] In this group of aplasia cutis congenita, the scalp lesions tend to be large. The most common limb malformation is hypoplastic or absent distal phalanges, but the severity of limb anomalies ranges from minor defects such as an absent nail or broad fingertip to more severe involvement. Limb anomalies are usually asymmetric and more commonly involve the lower extremities. Other anomalies may include cutis marmorata telangiectatica congenita, hemangiomas, cranial arteriovenous malformation, congenital heart defects, skin tags, supernumerary nipples, and woolly hair.
This is scalp aplasia cutis congenita with epidermal and sebaceous (organoid) nevi,[25, 26] also involving the scalp usually adjacent to the aplasia cutis. Some patients have also had ophthalmic and neurologic findings typical of epidermal nevus syndrome, including seizures, mental retardation, corneal opacities, and eyelid colobomas. SCALP syndrome has been proposed as an entity to describe the constellation of nevus Sebaceus, Central nervous system malformations, Aplasia cutis congenita, Limbal dermoid, and Pigmented nevus. Inheritance is sporadic.
This is aplasia cutis congenita overlying deeper embryologic malformations.[27, 28, 29, 30] Examples include meningomyelocele, porencephaly, leptomeningeal angiomatosis, cranial stenosis, spinal dysraphism, gastroschisis, and omphalocele. A hair collar is often present in the scalp lesions overlying neural tube defects. Intracranial arteriovenous malformations and fistulas have also been reported in association with scalp aplasia cutis congenita in rare cases. The inheritance pattern in this group varies with the associated underlying condition.
This is aplasia cutis congenita associated with fetus papyraceous or placental infarct.[32, 33, 34, 35, 36, 37, 38] Fetus papyraceous is found at the time of delivery and results from the death of a twin fetus in the late first or early second trimester. The surviving fetus is affected with extensive truncal and limb aplasia cutis congenita in a linear or stellate configuration but is usually otherwise normal.
This is aplasia cutis congenita associated with epidermolysis bullosa (EB),[39, 40, 41] , also referred to as Bart syndrome. Aplasia cutis congenita can be seen with any type of EB (simplex, junctional, or dystrophic). Many reports describe aplasia cutis congenita usually occurring on the lower extremities. A subgroup includes the association of pyloric or duodenal atresia, ureteral stenosis, renal abnormalities, craniofacial abnormalities, nail dystrophy, and aplasia cutis congenita.
This is aplasia cutis congenita localized to the extremities without EB.[42, 43, 44] At least two families have been reported in which multiple members have had extensive aplasia cutis congenita on the pretibial lower extremities and the dorsal aspects of the hands and the feet.
This is aplasia cutis congenita due to teratogens. A few cases of aplasia cutis congenita have been linked to intrauterine infection with herpes simplex virus or varicella zoster virus or to exposure to methimazole[45, 46, 47, 48] in the treatment of maternal thyrotoxicosis during pregnancy. Imperforate anus has been associated with methimazole or carbimazole exposure during gestation.
This is aplasia cutis congenita associated with malformation syndromes.[49, 50] Aplasia cutis congenita has been reported as a characteristic in many syndromes,[51, 52, 53, 54] including trisomy 13 (Patau syndrome) with large membranous scalp defects; 4p- (Wolf-Hirschhorn) syndrome with midline scalp defects; Setleis syndrome with bitemporal aplasia cutis congenita and abnormal eyelashes; Johanson-Blizzard syndrome with stellate scalp defects; focal dermal hypoplasia (Goltz syndrome); amniotic band disruption complex; oculocerebrocutaneous (Delleman) syndrome; scalp-ear-nipple syndrome (Finlay-Mark syndrome) ; Kabuki syndrome ; and 46XY gonadal dysgenesis. Reticulolinear aplasia cutis congenita on the face and neck is a distinctive cutaneous manifestation in several syndromes linked to band Xp22.
The exact pathophysiology of aplasia cutis congenita (ACC) is unclear. Proposed mechanisms include intrauterine trauma, vascular compromise, infection, and medications. It has been theorized that stellate or angulated lesions in particular result from vascular abnormalities or intrauterine ischemia.
Aplasia cutis congenita is typically sporadic; however, autosomal dominant and, less commonly autosomal recessive, cases have also been reported. Mutations in the ribosomal GTPase BMS1 have been identified as one cause of autosomal dominant aplasia cutis congenita. Familial aplasia cutis congenita on the scalp is generally nonmembranous, whereas membranous aplasia cutis congenita of the scalp is usually sporadic.
Aplasia cutis congenita (ACC) is an uncommon anomaly of newborns. More than 500 cases have been reported since it was first described, but because of significant underreporting of this generally benign disorder, the precise frequency is unknown. One estimate of incidence is approximately 3 in 10,000 births.
No racial predilection is reported for aplasia cutis congenita.
Unless associated with an X-linked malformation syndrome, no sexual predilection exists in aplasia cutis congenita.
Aplasia cutis congenita lesions are present at birth.
The prognosis for aplasia cutis congenita (ACC) is usually excellent. If the defect is small, recovery is uneventful, with gradual epithelialization and formation of a hairless, atrophic scar over several weeks. Small underlying bony defects usually close spontaneously during the first year of life. Surgical repair of large or multiple scalp defects with excision and primary closure, if feasible, or with the use of tissue expanders and rotation of a flap, may be considered. Truncal and limb defects, despite their large size, usually epithelialize and form atrophic scars, which can later be revised if necessary.
If aplasia cutis congenita is associated with other anomalies, the prognosis is dependent on the severity of the associated abnormalities. Underlying or associated defects may significantly affect mortality and morbidity. Full-thickness defects of the scalp, skull, and dura are associated with a mortality rate of greater than 50%. Even large defects on areas other than the scalp usually heal well with conservative skin care using topical antibiotic ointment. The rare larger scalp defects are prone to complications of hemorrhage and infection, placing patients at risk for death. Extensive aplasia cutis congenita of the scalp may be associated with an increased risk of sagittal sinus thrombosis. For these reasons, surgical intervention may be required for large, full-thickness scalp defects.
Genetic counseling is advised for parents of affected individuals if there is a strong family history of aplasia cutis congenita (ACC) or if the affected children have aplasia cutis congenita in association with a malformation syndrome.
Frieden IJ. Aplasia cutis congenita: a clinical review and proposal for classification. J Am Acad Dermatol. 1986 Apr. 14(4):646-60. [Medline].
Caksen H, Kurtoglu S. Our experience with aplasia cutis congenita. J Dermatol. 2002 Jun. 29(6):376-9. [Medline].
Moros Pena M, Labay Matias M, Valle Sanchez F, et al. [Aplasia cutis congenita in a newborn: etiopathogenic review and diagnostic approach]. An Esp Pediatr. 2000 May. 52(5):453-6. [Medline].
Vinay K, Yadav S, Parsad D, Abhijit C. Aplasia cutis congenita in a Blaschkoid distribution: a lesser known variant. Int J Dermatol. 2016 Jan 11. [Medline].
Hennekam RC. Aplasia cutis congenita reminiscent of the lines of Blaschko. Hum Genet. 1992 Dec. 90 (4):469-71. [Medline].
Rokunohe D, Akasaka E, Rokunohe A, Kaneko T, Matsuzaki Y, Takiyoshi N, et al. Multiple aplasia cutis congenita lesions located along Blaschko's lines in a patient with tetralogy of Fallot-A. J Dermatol Case Rep. 2012 Jun 30. 6 (2):40-2. [Medline].
Drolet B, Prendiville J, Golden J, Enjolras O, Esterly NB. Membranous aplasia cutis' with hair collars. Congenital absence of skin or neuroectodermal defect?. Arch Dermatol. 1995 Dec. 131(12):1427-31. [Medline].
Colon-Fontanez F, Fallon Friedlander S, Newbury R, Eichenfield LF. Bullous aplasia cutis congenita. J Am Acad Dermatol. 2003 May. 48(5 Suppl):S95-8. [Medline].
Benjamin LT, Trowers AB, Schachner LA. Giant aplasia cutis congenita without associated anomalies. Pediatr Dermatol. 2004 Mar-Apr. 21(2):150-3. [Medline].
Chitnis MR, Carachi R, Galea P. Familial aplasia cutis congenita. Eur J Pediatr Surg. 1996 Apr. 6(2):100-1. [Medline].
Fagan LL, Harris PA, Coran AG, Cywes R. Sporadic aplasia cutis congenita. Pediatr Surg Int. 2002 Sep. 18(5-6):545-7. [Medline].
Davidson AW, Hosalkar HS, Hill RA, Monsell F. Radial dysplasia with localized cutis aplasia congenita. J Pediatr Orthop B. 2003 Nov. 12(6):398-401. [Medline].
Balasubramanian M, Collins AL. Aplasia cutis congenita, terminal limb defects and periventricular leukomalacia in one sibling with minor findings in the other-probable autosomal recessive Adams-Oliver Syndrome. Eur J Med Genet. 2009 Jul-Aug. 52(4):234-8. [Medline].
Bilginer B, Onal MB, Bahadir S, Akalan N. Aplasia cutis congenita of the scalp, skull and dura associated with Adams-Oliver syndrome. Turk Neurosurg. 2008 Apr. 18(2):191-3. [Medline].
Dyall-Smith D, Ramsden A, Laurie S. Adams-Oliver syndrome: aplasia cutis congenita, terminal transverse limb defects and cutis marmorata telangiectatica congenita. Australas J Dermatol. 1994. 35(1):19-22. [Medline].
Orstavik KH, Stromme P, Spetalen S, et al. Aplasia cutis congenita associated with limb, eye, and brain anomalies in sibs: a variant of the Adams-Oliver syndrome?. Am J Med Genet. 1995 Oct 23. 59(1):92-5. [Medline].
Temtamy SA, Aglan MS, Ashour AM, Zaki MS. Adams-Oliver syndrome: further evidence of an autosomal recessive variant. Clin Dysmorphol. 2007 Jul. 16(3):141-9. [Medline].
Meester JA, Southgate L, Stittrich AB, Venselaar H, Beekmans SJ, den Hollander N, et al. Heterozygous Loss-of-Function Mutations in DLL4 Cause Adams-Oliver Syndrome. Am J Hum Genet. 2015 Sep 3. 97 (3):475-82. [Medline].
Hassed SJ, Wiley GB, Wang S, Lee JY, Li S, Xu W, et al. RBPJ mutations identified in two families affected by Adams-Oliver syndrome. Am J Hum Genet. 2012 Aug 10. 91 (2):391-5. [Medline].
Shaheen R, Aglan M, Keppler-Noreuil K, Faqeih E, Ansari S, Horton K, et al. Mutations in EOGT confirm the genetic heterogeneity of autosomal-recessive Adams-Oliver syndrome. Am J Hum Genet. 2013 Apr 4. 92 (4):598-604. [Medline].
Shaheen R, Faqeih E, Sunker A, Morsy H, Al-Sheddi T, Shamseldin HE, et al. Recessive mutations in DOCK6, encoding the guanidine nucleotide exchange factor DOCK6, lead to abnormal actin cytoskeleton organization and Adams-Oliver syndrome. Am J Hum Genet. 2011 Aug 12. 89 (2):328-33. [Medline].
Southgate L, Machado RD, Snape KM, Primeau M, Dafou D, Ruddy DM, et al. Gain-of-function mutations of ARHGAP31, a Cdc42/Rac1 GTPase regulator, cause syndromic cutis aplasia and limb anomalies. Am J Hum Genet. 2011 May 13. 88 (5):574-85. [Medline].
Stittrich AB, Lehman A, Bodian DL, Ashworth J, Zong Z, Li H, et al. Mutations in NOTCH1 cause Adams-Oliver syndrome. Am J Hum Genet. 2014 Sep 4. 95 (3):275-84. [Medline].
Narang T, Kanwar AJ, Dogra S. Adams-Oliver syndrome: a sporadic occurrence with minimal disease expression. Pediatr Dermatol. 2008 Jan-Feb. 25(1):115-6. [Medline].
Lam J, Dohil MA, Eichenfield LF, Cunningham BB. SCALP syndrome: sebaceous nevus syndrome, CNS malformations, aplasia cutis congenita, limbal dermoid, and pigmented nevus (giant congenital melanocytic nevus) with neurocutaneous melanosis: a distinct syndromic entity. J Am Acad Dermatol. 2008 May. 58(5):884-8. [Medline].
Neri I, Savoia F, Giacomini F, Raone B, Aprile S, Patrizi A. Usefulness of dermatoscopy for the early diagnosis of sebaceous naevus and differentiation from aplasia cutis congenita. Clin Exp Dermatol. 2009 Jul. 34(5):e50-2. [Medline].
Kantor J, Yan AC, Hivnor CM, Honig PJ, Kirschner R. Extensive aplasia cutis congenita and the risk of sagittal sinus thrombosis. Arch Dermatol. 2005 May. 141(5):554-6. [Medline].
Kim CS, Tatum SA, Rodziewicz G. Scalp aplasia cutis congenita presenting with sagittal sinus hemorrhage. Arch Otolaryngol Head Neck Surg. 2001 Jan. 127(1):71-4. [Medline].
Lane W, Zanol K. Duodenal atresia, biliary atresia, and intestinal infarct in truncal aplasia cutis congenita. Pediatr Dermatol. 2000 Jul-Aug. 17(4):290-2. [Medline].
Ribuffo D, Costantini M, Gullo P, Houseman ND, Taylor GI. Aplasia cutis congenita of the scalp, the skull, and the dura. Scand J Plast Reconstr Surg Hand Surg. 2003. 37(3):176-80. [Medline].
Gómez M, Chiesura V, Noguera-Morel L, Hernández-Martín A, García-Peñas JJ, Torrelo A. Extensive Intracranial Arteriovenous Malformation in a Child with Aplasia Cutis Congenita. Pediatr Dermatol. 2015 Jul-Aug. 32 (4):e163-4. [Medline].
Kelly BJ, Samolitis NJ, Xie DL, Skidmore RA. Aplasia cutis congenita of the trunk with fetus papyraceus. Pediatr Dermatol. 2002 Jul-Aug. 19(4):326-9. [Medline].
Maccario S, Fasolato V, Brunelli A, Martinelli S. Aplasia cutis congenita: an association with vanishing twin syndrome. Eur J Dermatol. 2009 Jul-Aug. 19(4):372-4. [Medline].
Schaffer JV, Popiolek DA, Orlow SJ. Symmetric truncal aplasia cutis congenita following multifetal reduction of a sextuplet pregnancy. J Pediatr. 2008 Dec. 153(6):860-3. [Medline].
Simman R. Reconstruction aplasia cutis congenita (group V) of the trunk in a newborn. Plast Reconstr Surg. 2004 Mar. 113(3):1103. [Medline].
Visva-Lingam S, Jana A, Murray H, John E. Preterm premature rupture of membranes associated with aplasia cutis congenita and fetus papyraceous. Aust N Z J Obstet Gynaecol. 1996 Feb. 36(1):90-1. [Medline].
Pieretti ML, Alcalá R, Boggio P, Noguera-Morel L, Porriño ML, Luna PC, et al. Aplasia Cutis Congenita Associated with Fetus Papyraceus. Pediatr Dermatol. 2015 Nov-Dec. 32 (6):858-61. [Medline].
Chan RK, Liu AS, Rogers GF. Aplasia cutis congenita of the trunk associated with fetus papyraceous. J Craniofac Surg. 2012 Jul. 23(4):995-7. [Medline].
McCarthy MA, Clarke T, Powell FC. Epidermolysis bullosa and aplasia cutis. Int J Dermatol. 1991 Jul. 30(7):481-4. [Medline].
Bigliardi PL, Braschler C, Kuhn P, Sigrist J, Buechner S, Rufli T. Unilateral aplasia cutis congenita on the leg. Pediatr Dermatol. 2004 Jul-Aug. 21(4):454-7. [Medline].
Benvenuto C, Kraemer CK, Kruse RL, Cestari TF. Familial epidermolysis bullosa with aplasia cutis congenita: Bart's syndrome?. Skinmed. 2003 Sep-Oct. 2(5):319-21. [Medline].
Atik B, Tan O, Bayram I, Tuncer O, Kirimi E. Asymmetrical nonscalp aplasia cutis congenita: a case report. J Dermatol. 2004 Nov. 31(11):923-6. [Medline].
Boente Mdel C, Frontini Mdel V, Acosta MI, Saleme C, Barrionuevo S, Asial R. Extensive symmetric truncal aplasia cutis congenita without fetus papyraceus or macroscopic evidence of placental abnormalities. Pediatr Dermatol. 1995 Sep. 12(3):228-30. [Medline].
Morrell DS, Rubenstein DS, Briggaman RA, Fine JD, Pulkkinen L, Uitto J. Congenital pyloric atresia in a newborn with extensive aplasia cutis congenita and epidermolysis bullosa simplex. Br J Dermatol. 2000 Dec. 143(6):1342-3. [Medline].
Izhar R, Ghani T. Aplasia cutis congenita and antithyroid drugs. J Pak Med Assoc. 2002 Nov. 52(11):526-8. [Medline].
Karg E, Bereg E, Gaspar L, Katona M, Turi S. Aplasia cutis congenita after methimazole exposure in utero. Pediatr Dermatol. 2004 Jul-Aug. 21(4):491-4. [Medline].
Mandel SJ, Brent GA, Larsen PR. Review of antithyroid drug use during pregnancy and report of a case of aplasia cutis. Thyroid. 1994 Spring. 4(1):129-33. [Medline].
Nakamura S, Nishikawa T, Isaji M, et al. Aplasia cutis congenita and skull defects after exposure to methimazole in utero. Intern Med. 2005 Nov. 44(11):1202-3. [Medline].
Evers ME, Steijlen PM, Hamel BC. Aplasia cutis congenita and associated disorders: an update. Clin Genet. 1995 Jun. 47(6):295-301. [Medline].
Casanova D, Amar E, Bardot J, Magalon G. Aplasia cutis congenita. Report on 5 family cases involving the scalp. Eur J Pediatr Surg. 2001 Aug. 11(4):280-4. [Medline].
Rodrigues RG. Aplasia cutis congenita, congenital heart lesions, and frontonasal cysts in four successive generations. Clin Genet. 2007 Jun. 71(6):558-60. [Medline].
Teebi AS, Druker HA. Brachycephaly, cutis aplasia congenita, blue sclerae, hypertelorism, polydactyly, hypoplastic nipples, failure to thrive, and developmental delay: a distinct autosomal recessive syndrome?. Clin Dysmorphol. 2001 Jan. 10(1):69-70. [Medline].
Sugiura T, Kouwaki M, Kiyosawa S, et al. A case of systemic aplasia cutis congenita: a newly recognized syndrome?. Eur J Pediatr. 2008 Apr. 167(4):409-13. [Medline].
Marneros AG, Beck AE, Turner EH, McMillin MJ, Edwards MJ, Field M, et al. Mutations in KCTD1 cause scalp-ear-nipple syndrome. Am J Hum Genet. 2013 Apr 4. 92 (4):621-6. [Medline].
Canham NL. Cutis aplasia as a feature of Kabuki syndrome. Clin Dysmorphol. 2006 Jul. 15(3):179-80. [Medline].
Baselga E, Torrelo A, Drolet BA, Zambrano A, Alomar A, Esterly NB. Familial nonmembranous aplasia cutis of the scalp. Pediatr Dermatol. 2005 May-Jun. 22(3):213-7. [Medline].
Gerber M, de Veciana M, Towers CV, Devore GR. Aplasia cutis congenita: a rare cause of elevated alpha-fetoprotein levels. Am J Obstet Gynecol. 1995 Mar. 172(3):1040-1. [Medline].
Drolet BA, Clowry L Jr, McTigue MK, Esterly NB. The hair collar sign: marker for cranial dysraphism. Pediatrics. 1995 Aug. 96(2 Pt 1):309-13. [Medline].
Browning JC. Aplasia cutis congenita: approach to evaluation and management. Dermatol Ther. 2013 Nov. 26(6):439-44. [Medline].
Santos de Oliveira R, Barros Juca CE, Lopes Lins-Neto A, Aparecida do Carmo Rego M, Farina J, Machado HR. Aplasia cutis congenita of the scalp: is there a better treatment strategy?. Childs Nerv Syst. 2006 Sep. 22(9):1072-9. [Medline].
Gan YC, Steinbok P. Aplasia cutis congenita of the scalp: is there a better treatment strategy?. Childs Nerv Syst. 2006 Oct. 22(10):1216-7; author reply 1218-9. [Medline].
Ahcan U, Janezic T. Management of aplasia cutis congenita in a non-scalp location. Br J Plast Surg. 2002 Sep. 55(6):530-2. [Medline].
Bang RL, Ghoneim IE, Gang RK, Al Najjadah I. Treatment dilemma: conservative versus surgery in cutis aplasia congenita. Eur J Pediatr Surg. 2003 Apr. 13(2):125-9. [Medline].
Donati V, Arena S, Capilli G, Carrera G, Ciralli F, Liberatore A. Reparation of a severe case of aplasia cutis congenita with engineered skin. Biol Neonate. 2001. 80(4):273-6. [Medline].
Madsen JR, Robertson RL, Bartlett R. Surgical management of cutis aplasia with high-flow sinus pericranii. Pediatr Neurosurg. 1998 Feb. 28(2):79-83. [Medline].
Rhee ST, Colville C, Buchman SR, Muraszko K. Complete osseous regeneration of a large skull defect in a patient with cutis aplasia: a conservative approach. J Craniofac Surg. 2002 Jul. 13(4):497-500. [Medline].
Shivakumar SK, Dwarakanath S, Swaroop G, Venkataramana NK. Aplasia cutis congenita of the scalp: therapeutic modalities. Neurol India. 2006 Sep. 54(3):312-3. [Medline].
Skoufi G, Lialios G, Plachouras N, Kutsogiannis D, Mperis A. Aplasia cutis congenita: Successful conservative treatment. Pediatr Int. 2006 Oct. 48(5):507-9. [Medline].
Maillet-Declerck M, Vinchon M, Guerreschi P, Pasquesoone L, Dhellemmes P, Duquennoy-Martinot V, et al. Aplasia Cutis Congenita: Review of 29 Cases and Proposal of a Therapeutic Strategy. Eur J Pediatr Surg. 2012 Aug 17. [Medline].
Azad S, Falder S, Harrison J, Graham K. An adherent dressing for aplasia cutis congenita. Br J Plast Surg. 2005 Dec. 58(8):1159-61. [Medline].
Lahiri A, Nishikawa H. A nonadherent dressing for aplasia cutis congenita. J Plast Reconstr Aesthet Surg. 2006. 59(7):781-2. [Medline].